???pagination.result.count???
???pagination.result.page???
1
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery. , O'Connor EC., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.
GABAA receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β. , Ruffolo G., Sci Rep. October 26, 2022; 12 (1): 17956.
Sea anemone Bartholomea annulata venom inhibits voltage-gated Na+ channels and activates GABAA receptors from mammals. , Colom-Casasnovas A., Sci Rep. March 30, 2022; 12 (1): 5352.
Targeting GABAC Receptors Improves Post-Stroke Motor Recovery. , van Nieuwenhuijzen PS., Brain Sci. March 2, 2021; 11 (3):
GABAA Receptor Subunit Composition Drives Its Sensitivity to the Insecticide Fipronil. , Soualah Z., Front Neurosci. January 1, 2021; 15 768466.
Competitive Antagonism of Etomidate Action by Diazepam. , McGrath M., Anesthesiology. January 1, 2020; 133 (3): 583-594.
Suramin is a novel competitive antagonist selective to α1β2γ2 GABAA over ρ1 GABAC receptors. , Luo H., Neuropharmacology. October 1, 2018; 141 148-157.
Differential modulation of human GABAC-ρ1 receptor by sulfur-containing compounds structurally related to taurine. , Ochoa-de la Paz LD., BMC Neurosci. August 3, 2018; 19 (1): 47.
Direct neurotransmitter activation of voltage-gated potassium channels. , Manville RW., Nat Commun. May 10, 2018; 9 (1): 1847.
Structural Basis for a Bimodal Allosteric Mechanism of General Anesthetic Modulation in Pentameric Ligand-Gated Ion Channels. , Fourati Z., Cell Rep. April 24, 2018; 23 (4): 993-1004.
Diversity of Nicotinic Acetylcholine Receptor Positive Allosteric Modulators Revealed by Mutagenesis and a Revised Structural Model. , Newcombe J., Mol Pharmacol. February 1, 2018; 93 (2): 128-140.
Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant. , Shelukhina IV., Toxins (Basel). January 7, 2018; 10 (1):
Negative modulation of the GABAA ρ1 receptor function by l-cysteine. , Beltrán González AN., J Neurochem. January 1, 2018; 144 (1): 50-57.
Expression and purification of a functional heteromeric GABAA receptor for structural studies. , Claxton DP., PLoS One. January 1, 2018; 13 (7): e0201210.
The novel isoxazoline ectoparasiticide lotilaner (Credelio™): a non-competitive antagonist specific to invertebrates γ-aminobutyric acid-gated chloride channels (GABACls). , Rufener L., Parasit Vectors. November 1, 2017; 10 (1): 530.
Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes. , Simeone X., Sci Rep. July 18, 2017; 7 (1): 5674.
Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin. , Morano A., Epilepsia Open. September 19, 2016; 1 (3-4): 145-151.
Zolpidem is a potent stoichiometry-selective modulator of α1β3 GABAA receptors: evidence of a novel benzodiazepine site in the α1-α1 interface. , Che Has AT., Sci Rep. June 27, 2016; 6 28674.
Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors. , Ziemba AM., PLoS One. April 21, 2016; 11 (4): e0154031.
Signal Transduction at the Domain Interface of Prokaryotic Pentameric Ligand-Gated Ion Channels. , Bertozzi C., PLoS Biol. March 4, 2016; 14 (3): e1002393.
Contrasting actions of a convulsant barbiturate and its anticonvulsant enantiomer on the α1 β3 γ2L GABAA receptor account for their in vivo effects. , Desai R., J Physiol. November 15, 2015; 593 (22): 4943-61.
The Direct Actions of GABA, 2'-Methoxy-6-Methylflavone and General Anaesthetics at β3γ2L GABAA Receptors: Evidence for Receptors with Different Subunit Stoichiometries. , Chua HC., PLoS One. October 20, 2015; 10 (10): e0141359.
Interactions of L-3,5,3'-Triiodothyronine [corrected], Allopregnanolone, and Ivermectin with the GABAA Receptor: Evidence for Overlapping Intersubunit Binding Modes. , Westergard T., PLoS One. September 4, 2015; 10 (9): e0139072.
The desensitization gate of inhibitory Cys-loop receptors. , Gielen M., Nat Commun. April 20, 2015; 6 6829.
Hydrocarbon molar water solubility predicts NMDA vs. GABAA receptor modulation. , Brosnan RJ., BMC Pharmacol Toxicol. November 19, 2014; 15 62.
Partial agonism of taurine at gamma-containing native and recombinant GABAA receptors. , Kletke O., PLoS One. January 1, 2013; 8 (4): e61733.
Macroscopic kinetics of pentameric ligand gated ion channels: comparisons between two prokaryotic channels and one eukaryotic channel. , Laha KT., PLoS One. January 1, 2013; 8 (11): e80322.
GABAergic circuits control stimulus-instructed receptive field development in the optic tectum. , Richards BA., Nat Neurosci. September 1, 2010; 13 (9): 1098-106.
m-Azipropofol (AziPm) a photoactive analogue of the intravenous general anesthetic propofol. , Hall MA., J Med Chem. August 12, 2010; 53 (15): 5667-75.
An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition. , Dawson GR., J Pharmacol Exp Ther. March 1, 2006; 316 (3): 1335-45.
Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. , Huang SH., Eur J Pharmacol. June 28, 2004; 494 (2-3): 131-8.
Neuronal representation of odourants in the olfactory bulb of Xenopus laevis tadpoles. , Czesnik D., Eur J Neurosci. January 1, 2003; 17 (1): 113-8.
Inhibitory effects of corymine, an alkaloidal component from the leaves of Hunteria zeylanica, on glycine receptors expressed in Xenopus oocytes. , Leewanich P., Eur J Pharmacol. August 13, 1997; 332 (3): 321-6.
A functional comparison of the antagonists bicuculline and picrotoxin at recombinant GABAA receptors. , Krishek BJ., Neuropharmacology. January 1, 1996; 35 (9-10): 1289-98.
Alpha subunits influence Zn block of gamma 2 containing GABAA receptor currents. , White G., Neuroreport. February 15, 1995; 6 (3): 461-4.
A system for the translation of receptor messenger-RNA and the study of the assembly of functional receptors. , Barnard EA., J Recept Res. January 1, 1984; 4 (1-6): 681-704.